Stockreport

Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial

KIROMIC BIOPHARMA INC  (KRBP) 
PDF Follow-up Findings Show Stable DiseaseFDA and IRB Approve IND for a Single-Use, Single-Patient Treatment with DeltacelFast Track Designation Request Submitted to FDAComp [Read more]